Related Experiment Video
Updated: Aug 20, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe
1Robert Koch Institute, Wernigerode Branch, Burgstrasse 37, 38855 Wernigerode, Germany. wittew@rki.de
Abstract:
The aim of the present study was to investigate strains of methicillin-resistant Staphylococcus aureus (MRSA) for the presence of the lukS-lukF determinant of Panton-Valentine leukocidin and to further characterize strains found to contain the genes. During the past 2 years, MRSA containing the lukS-lukF genes for Panton-Valentine leukocidin, particularly those emerging outside of hospitals, have become of interest. MRSA strains sent to the national reference center in Germany were investigated for lukS-lukF by polymerase chain reaction (PCR). If the presence of lukS-lukF was demonstrated, strains were further characterized by molecular typing (determination of SmaI pattern, spa sequence, and multilocus sequence type), PCR demonstration of resistance genes, and characterization of the SCCmec element. Since the end of 2002, MRSA containing Panton-Valentine leukocidin genes have been demonstrated as the causative agent of 28 cases of infection (9 community-acquired cases, 19 sporadic nosocomial cases) in different areas of Germany. Twenty-seven of these 28 isolates exhibited a unique pattern of genomic typing: all exhibited multilocus sequence type 80, spa sequence type 44, and a SmaI macrorestriction pattern that corresponds to a community-acquired strain of MRSA from France and Switzerland. In addition to resistance to oxacillin, the strains exhibited resistance to ciprofloxacin, tetracycline (tetM), and fusidic acid, the last of which is encoded by the far-1 gene. The far-1 gene was shown to be located on the plasmid. One isolate corresponded to community MRSA (cMRSA) of multilocus sequence type 1 from the USA.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) strains carrying Panton-Valentine leukocidin genes were identified in Germany. These MRSA strains showed specific genetic profiles and resistance to multiple antibiotics, including community-acquired MRSA.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) strains producing Panton-Valentine leukocidin (PVL) are of increasing concern, especially those emerging in community settings.
- PVL is a toxin associated with severe staphylococcal infections, and its genetic determinant (lukS-lukF) is a key virulence factor.
Purpose of the Study:
- To investigate German MRSA strains for the presence of the lukS-lukF genes encoding PVL.
- To characterize MRSA strains positive for PVL genes regarding their molecular typing, resistance profiles, and SCCmec elements.
Main Methods:
- Polymerase chain reaction (PCR) was used to detect the lukS-lukF determinant in MRSA strains.
- Molecular typing included SmaI macrorestriction, spa sequencing, and multilocus sequence typing (MLST).
- Resistance genes and SCCmec elements were also characterized by PCR.
Main Results:
- Since late 2002, 28 MRSA infections in Germany were linked to PVL-producing strains (9 community-acquired, 19 nosocomial).
- Twenty-seven of these isolates shared a common genomic profile: MLST type 80, spa type 44, and a SmaI pattern consistent with French/Swiss community-acquired MRSA.
- These strains were resistant to oxacillin, ciprofloxacin, tetracycline (tetM), and fusidic acid (encoded by plasmid-located far-1 gene).
Conclusions:
- PVL-producing MRSA strains, particularly MLST type 80, have emerged in Germany, causing both community and hospital-acquired infections.
- These strains possess a distinct genetic background and a multi-drug resistance pattern, highlighting the need for surveillance.
- One isolate represented a US-origin community MRSA (cMRSA) with MLST type 1.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Development of Antibiotic Resistance